Psoriasis-associated impairment of CCL27/CCR10-derived regulation leads to IL-17A/IL-22-producing skin T-cell overactivation

J Allergy Clin Immunol. 2021 Feb;147(2):759-763.e9. doi: 10.1016/j.jaci.2020.05.044. Epub 2020 Jun 10.

Abstract

Psoriasis-associated suppression of the skin-specific chemokine/receptor CCL27/CCR10 axis leads to enhanced pathogenic IL-17A/IL-22-producing skin T cell activation and inflammation.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Chemokine CCL27 / immunology*
  • Interleukin-17 / immunology
  • Interleukin-22
  • Interleukins / immunology
  • Lymphocyte Activation / immunology*
  • Mice
  • Psoriasis / immunology*
  • Receptors, CCR10 / immunology*
  • Skin / immunology
  • T-Lymphocytes / immunology*

Substances

  • Chemokine CCL27
  • Interleukin-17
  • Interleukins
  • Receptors, CCR10